基本信息
views: 112
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Awards and Honors
Damon Runyon Cancer Research Foundation 2018 - 2021 Damon Runyon Clinical Investigator Award
Doris Duke Charitable Foundation 2018 - 2012 Clinical Scientist Award
V Foundation 2018 - 2020 V Scholar Award
AACR 2014 - 2016 AACR BioOncology Fellowship
Uniting Against Lung Cancer 2014 - 2016 Legacy Award
Bonnie J. Addario Lung Cancer Foundation 2013 Research Grant
Overview
Dr. Blakely is a medical oncologist specializing in the treatment of lung cancer. He received his Bachelor of Science degree in Molecular and Cellular Biology from the University of Washington and attended the Perelman School of Medicine at the University of Pennsylvania in the Medical Scientist Training Program. He completed his Internal Medicine residency at the Hospital of the University of Pennsylvania and trained as a clinical fellow in Medical Oncology at UCSF. His research focuses on understanding the cellular and molecular mechanisms underlying lung cancer resistance to EGFR-, and ALK-targeted therapies, and identifying new targets for molecular-directed therapies. His goal is to translate laboratory-based findings into new treatments for lung cancer patients.
Interests
Non-small cell lung cancer, EGFR, ALK, ROS-1, Cancer Genomics, Targeted Therapies
Damon Runyon Cancer Research Foundation 2018 - 2021 Damon Runyon Clinical Investigator Award
Doris Duke Charitable Foundation 2018 - 2012 Clinical Scientist Award
V Foundation 2018 - 2020 V Scholar Award
AACR 2014 - 2016 AACR BioOncology Fellowship
Uniting Against Lung Cancer 2014 - 2016 Legacy Award
Bonnie J. Addario Lung Cancer Foundation 2013 Research Grant
Overview
Dr. Blakely is a medical oncologist specializing in the treatment of lung cancer. He received his Bachelor of Science degree in Molecular and Cellular Biology from the University of Washington and attended the Perelman School of Medicine at the University of Pennsylvania in the Medical Scientist Training Program. He completed his Internal Medicine residency at the Hospital of the University of Pennsylvania and trained as a clinical fellow in Medical Oncology at UCSF. His research focuses on understanding the cellular and molecular mechanisms underlying lung cancer resistance to EGFR-, and ALK-targeted therapies, and identifying new targets for molecular-directed therapies. His goal is to translate laboratory-based findings into new treatments for lung cancer patients.
Interests
Non-small cell lung cancer, EGFR, ALK, ROS-1, Cancer Genomics, Targeted Therapies
Research Interests
Papers共 145 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
biorxiv(2024)
Nature cancerno. 6 (2024): 938-952
Clinical Lung Cancer (2024)
Current problems in cancer (2024): 101065-101065
Nature communicationsno. 1 (2024): 4871-4871
CANCER RESEARCHno. 7 (2023)
Jacqueline V. Aredo,Anatoly Urisman,Matthew A. Gubens,Claire Mulvey,Greg M. Allen,Julia K. Rotow,Daniel Lucas Kerr, Turja Chakrabarti, Bianca Bacaltos, Megan Gee,Kirk Jones,Dara L. Aisner,
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)
Cited0Views0Bibtex
0
0
openalex(2023)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn